MTPConnect recently held a virtual industry roundtable to launch the formation of Australia’s first Antimicrobial Resistance Network – the AAMRNet, and released a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders’, prepared by MTPConnect in partnership with Biointelect.

Collaboration is the key to success and the AAMRNet aims to provide a unified voice to support and promote Australia’s role in the global fight against the growing threat of drug resistant infections. MTPConnect’s Managing Director and CEO, Dr Dan Grant officially launched the initiative, followed by a discussion with AAMRNet’s Steering Committee members facilitated by Jenny Herz, Biointelect Managing Director. 

Panellists included:

• Elizabeth de Somer - CEO, Medicines Australia 
• Professor David Paterson - Director UQ Centre for Clinical Research, Faculty of Medicine at University of Queensland 
• Paul Field - Australian Representative, Global Antibiotic Research and Development Partnership (GARDP) and Foundation for Innovative New Diagnostics (FIND) 
• Julie Philips - Managing Director, Opal Biosciences and MTPConnect Director.

 To find out more or to join the AAMRNet, contact MTPConnect.